222 related articles for article (PubMed ID: 26942655)
1. Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less.
Schiffer JM; McNeil MM; Quinn CP
Expert Rev Vaccines; 2016 Sep; 15(9):1151-62. PubMed ID: 26942655
[TBL] [Abstract][Full Text] [Related]
2. Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule.
Longstreth J; Skiadopoulos MH; Hopkins RJ
Expert Rev Vaccines; 2016 Dec; 15(12):1467-1479. PubMed ID: 27792416
[TBL] [Abstract][Full Text] [Related]
3. Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.
Schiffer JM; Chen L; Dalton S; Niemuth NA; Sabourin CL; Quinn CP
Vaccine; 2015 Jul; 33(31):3709-16. PubMed ID: 26072016
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
[TBL] [Abstract][Full Text] [Related]
5. Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing.
Stark GV; Sivko GS; VanRaden M; Schiffer J; Taylor KL; Hewitt JA; Quinn CP; Nuzum EO
Vaccine; 2016 Dec; 34(51):6512-6517. PubMed ID: 27558619
[TBL] [Abstract][Full Text] [Related]
6. Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019.
Bower WA; Schiffer J; Atmar RL; Keitel WA; Friedlander AM; Liu L; Yu Y; Stephens DS; Quinn CP; Hendricks K;
MMWR Recomm Rep; 2019 Dec; 68(4):1-14. PubMed ID: 31834290
[TBL] [Abstract][Full Text] [Related]
7. Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.
Wright JG; Plikaytis BD; Rose CE; Parker SD; Babcock J; Keitel W; El Sahly H; Poland GA; Jacobson RM; Keyserling HL; Semenova VA; Li H; Schiffer J; Dababneh H; Martin SK; Martin SW; Marano N; Messonnier NE; Quinn CP
Vaccine; 2014 Feb; 32(8):1019-28. PubMed ID: 24373307
[TBL] [Abstract][Full Text] [Related]
8. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
Wright JG; Quinn CP; Shadomy S; Messonnier N;
MMWR Recomm Rep; 2010 Jul; 59(RR-6):1-30. PubMed ID: 20651644
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis.
Ionin B; Hopkins RJ; Pleune B; Sivko GS; Reid FM; Clement KH; Rudge TL; Stark GV; Innes A; Sari S; Guina T; Howard C; Smith J; Swoboda ML; Vert-Wong E; Johnson V; Nabors GS; Skiadopoulos MH
Clin Vaccine Immunol; 2013 Jul; 20(7):1016-26. PubMed ID: 23658392
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.
Hopkins RJ; Kalsi G; Montalvo-Lugo VM; Sharma M; Wu Y; Muse DD; Sheldon EA; Hampel FC; Lemiale L
Vaccine; 2016 Apr; 34(18):2096-105. PubMed ID: 26979136
[TBL] [Abstract][Full Text] [Related]
11. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
Quinn CP; Sabourin CL; Niemuth NA; Li H; Semenova VA; Rudge TL; Mayfield HJ; Schiffer J; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Brys AM; Hunt RE; Levesque D; Estep JE; Barnewall RE; Robinson DM; Plikaytis BD; Marano N;
Clin Vaccine Immunol; 2012 Nov; 19(11):1730-45. PubMed ID: 22933399
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers.
Hopkins RJ; Daczkowski NF; Kaptur PE; Muse D; Sheldon E; LaForce C; Sari S; Rudge TL; Bernton E
Vaccine; 2013 Jun; 31(30):3051-8. PubMed ID: 23701746
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis against anthrax.
Splino M; Patocka J
Acta Medica (Hradec Kralove); 2002; 45(3):85-8. PubMed ID: 12515043
[TBL] [Abstract][Full Text] [Related]
14. Anthrax vaccines.
Splino M; Patocka J; Prymula R; Chlibek R
Ann Saudi Med; 2005; 25(2):143-9. PubMed ID: 15977694
[TBL] [Abstract][Full Text] [Related]
15. Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.
Savransky V; Shearer JD; Gainey MR; Sanford DC; Sivko GS; Stark GV; Li N; Ionin B; Lacy MJ; Skiadopoulos MH
Vaccine; 2017 Sep; 35(37):4952-4959. PubMed ID: 28774566
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults.
Bernstein DI; Jackson L; Patel SM; El Sahly HM; Spearman P; Rouphael N; Rudge TL; Hill H; Goll JB
Vaccine; 2014 Oct; 32(47):6284-93. PubMed ID: 25239484
[TBL] [Abstract][Full Text] [Related]
17. Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.
Quinn CP; Sabourin CL; Schiffer JM; Niemuth NA; Semenova VA; Li H; Rudge TL; Brys AM; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Parker SD; Babcock J; Keitel W; Poland GA; Keyserling HL; El Sahly H; Jacobson RM; Marano N; Plikaytis BD; Wright JG
Clin Vaccine Immunol; 2016 Apr; 23(4):326-38. PubMed ID: 26865594
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart.
Shearer JD; Henning L; Sanford DC; Li N; Skiadopoulos MH; Reece JJ; Ionin B; Savransky V
Vaccine; 2021 Jan; 39(1):1-5. PubMed ID: 33199078
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents.
King JC; Gao Y; Quinn CP; Dreier TM; Vianney C; Espeland EM
Vaccine; 2015 May; 33(21):2470-6. PubMed ID: 25850022
[TBL] [Abstract][Full Text] [Related]
20. Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed.
Pittman PR; Cavicchia MA; Kingsbury JL; Johnson NA; Barrera-Oro JG; Schmader T; Korman L; Quinn X; Ranadive M
Vaccine; 2014 Sep; 32(39):5131-9. PubMed ID: 24837771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
